Why akero Is Trending Today?

Explore key developments that caused akero to trend — updated as the story unfolds.

1 key events detected

October 9, 2025 at 2:58 PM

Novo Nordisk, a leading diabetes care company, has agreed to acquire Akero Therapeutics, a biotechnology firm specializing in liver diseases, in a deal valued up to $5.2 billion. The acquisition, which is expected to close in the second half of 2023, will expand Novo Nordisk's portfolio into non-communicable liver diseases. Following the announcement, shares of Akero Therapeutics surged by approximately 20%, while Novo Nordisk's stock experienced a slight decline.